Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

Escalating concerns over impending tariffs and President Trump's foreign policies have fueled uncertainty and instability in ...

Supernus Pharmaceutical’s stock declined following the release of disappointing Phase IIb trial results for SPN-820, an ...

As shown in Figure 4, the odds of vortioxetine treated patients achieving a ≥50% MADRS score reduction from baseline was about 3 times higher than placebo treated patients (Overall OR = 2.87; 95 ...

The following is a summary of “Comparative effectiveness of short-term psychodynamic psychotherapy and cognitive behavioral ...

Ketamine can effectively treat depression, but whether depressed patients with alcohol use disorder can safely use ketamine ...

Ketamine can effectively treat depression, but whether depressed patients with alcohol use disorder can safely use ketamine repeatedly remains unclear clinically.

Thase, MD, professor of psychiatry at the Perelman School of Medicine at the University of Pennsylvania, discusses: The factors that can trigger major depressive disorders; Pharmacological options ...

NMDA receptor antagonists are a class of drugs that may treat memory loss and brain damage associated with Alzheimer’s disease and major depressive disorder (MDD). NMDA receptors allow the excitatory ...